Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The cost effectiveness of preoperative autologous blood donations.

Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, Fink A, Brook R.

N Engl J Med. 1995 Mar 16;332(11):719-24.

3.

Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes.

Vitale MG, Roye BD, Ruchelsman DE, Roye DP Jr.

Spine J. 2007 May-Jun;7(3):292-300. Epub 2006 Nov 14.

PMID:
17482112
4.

Preoperative autologous blood donation: clinical, economic, and ethical issues.

Domen RE.

Cleve Clin J Med. 1996 Sep;63(5):295-300. Review.

PMID:
8870340
5.

Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.

Dietrich W, Thuermel K, Heyde S, Busley R, Berger K.

J Cardiothorac Vasc Anesth. 2005 Oct;19(5):589-96.

PMID:
16202891
6.

Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis.

Healy JC, Frankforter SA, Graves BK, Reddy RL, Beck JR.

Arch Pathol Lab Med. 1994 Apr;118(4):465-70.

PMID:
8166599
7.

The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement.

Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B.

Transfusion. 1993 Jul;33(7):544-51.

PMID:
8333017
8.

Shed mediastinal blood transfusion after cardiac operations: a cost-effectiveness analysis.

Kilgore ML, Pacifico AD.

Ann Thorac Surg. 1998 May;65(5):1248-54.

PMID:
9594846
9.

Autologous transfusion and other approaches to reduce allogeneic blood exposure.

Vamvakas EC, Pineda AA.

Baillieres Best Pract Res Clin Haematol. 2000 Dec;13(4):533-47. Review.

PMID:
11102275
10.

Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.

Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C.

Health Technol Assess. 2006 Nov;10(44):iii-iv, ix-x, 1-210. Review.

11.

Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery.

Coyle D, Lee KM, Fergusson DA, Laupacis A.

Pharmacoeconomics. 2000 Aug;18(2):161-71.

PMID:
11067650
12.

Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.

Green WS, Toy P, Bozic KJ.

J Arthroplasty. 2010 Jan;25(1):93-6. doi: 10.1016/j.arth.2008.10.005. Epub 2008 Dec 3.

PMID:
19056224
13.
14.

The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion.

Sonnenberg FA, Gregory P, Yomtovian R, Russell LB, Tierney W, Kosmin M, Carson JL.

Transfusion. 1999 Aug;39(8):808-17.

PMID:
10504114
15.

Utilization of preoperative autologous blood donation in elective surgery.

Savoia HF, Metz J, Maxwell EL, Hauesler MN, Mellor J, Kiely S.

ANZ J Surg. 2002 Aug;72(8):557-60.

PMID:
12190728
16.

Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients.

Horowitz NS, Gibb RK, Menegakis NE, Mutch DG, Rader JS, Herzog TJ.

Obstet Gynecol. 2002 May;99(5 Pt 1):771-6.

PMID:
11978286
17.

A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery.

Blumberg N, Kirkley SA, Heal JM.

Am J Surg. 1996 Mar;171(3):324-30.

PMID:
8615466
18.
19.

The cost-effectiveness of screening the U.S. blood supply for West Nile virus.

Custer B, Busch MP, Marfin AA, Petersen LR.

Ann Intern Med. 2005 Oct 4;143(7):486-92.

PMID:
16204161
20.

[Autologous blood donation versus homologous blood transfusion--an analysis of cost effectiveness].

Dietrich GV.

Zentralbl Chir. 1996;121(10):841-6. Review. German.

PMID:
9019932

Supplemental Content

Support Center